The Team

BioCurate’s team brings decades of global experience, scientific and commercial expertise and proven success spanning therapeutic discovery, preclinical, clinical, regulatory and commercial areas. This expertise, together with a passion and commitment to create impact through translating discoveries into drugs, enables the team to recognise and realise real-world impact.

170
More than 170 years of combined biotech/pharma industry experience

13
Directly involved in over 13 Investigational New Drug applications (INDs)

30
Responsible for 30 therapeutics currently in the clinic

$2.4B
Directly involved in deals worth a cumulative total of more than $2.4 billion

Dr Kathy Nielsen
CEO
Kathy brings over 25 years of experience in senior leadership and advisory roles primarily in the life science sector, with deep experience in technology transfer, venture capital, creating and advancing spin out companies, and operating in the nexus between research and the pharmaceutical industry.

Read full profile
Metani Rooms
COO
Metani is a seasoned biopharmaceutical leader with extensive experience managing global and local matrix teams and overseeing major projects.

Read full profile
Chacko Joseph
Head of Drug Development
Dr Chacko Joseph is a seasoned life sciences professional with over a decade of experience in early-stage drug development, technology transfer, and strategic partnerships.

Read full profile
Dr Jaclyn Sceneay
Director of Translational Biology
Dr Jaclyn Sceneay is an immuno-oncologist with experience in small molecule and PROTAC drug discovery, and microbiome therapeutics.

Read full profile
Dr Tifelle Reisinger
Associate Director, Medicinal Chemistry Discovery and Stakeholder Management
Dr Tifelle Reisinger is a medicinal chemist with over 15 years’ experience in small drug discovery experience in the pharmaceutical industry and contract research organisations (CRO) in France, UK and Australia.

Read full profile
Dr Heique Bogdawa
Senior Scientist, Protein Sciences
Dr Heique Bogdawa is a biochemist with over 15 years protein engineering experience in the development of high-quality biological reagents and target validation assays for drug discovery.

Read full profile
Michele Neisemann
Operations Manager
Michele Neisemann is an experienced operations and administration professional with extensive experience spanning research and development, biotechnology, management consultancy, and legal environments.

Read full profile

Board of Directors

BioCurate is operationally independent and has an independent Board Chair, the Hon John Brumby, AO. Our Board of Directors has expertise in innovation, biotechnology, commercialisation, investment and corporate governance.

Discover more

 

Our Shareholders

Melbourne is home to two outstanding universities, Monash University and the University of Melbourne. Joining these two powerhouses to support the collaborative joint venture BioCurate, is the Victorian State Government, the nation’s largest investor in the life sciences.

Discover more

 

Portfolio

BioCurate’s portfolio of projects spans a number of therapeutic areas, from oncology to anti-infectives. These projects are currently receiving support from the BioCurate team and our network of local and global industry and sector partners.

Discover more